Differential activation of the μ‐opioid receptor by oxycodone and morphine in pain‐related brain regions in a bone cancer pain model

Bone cancer pain is chronic and often difficult to control with opioids. However, recent studies have shown that several opioids have distinct analgesic profiles in chronic pain.

[1]  Stephen P. H. Alexander,et al.  Guide to Receptors and Channels (GRAC), 5th edition , 2011, British journal of pharmacology.

[2]  Douglas G Altman,et al.  Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  C. Kilkenny,et al.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines , 2010, British journal of pharmacology.

[4]  M. Narita,et al.  Comparative Pharmacological Profiles of Morphine and Oxycodone under a Neuropathic Pain-Like State in Mice: Evidence for Less Sensitivity to Morphine , 2008, Neuropsychopharmacology.

[5]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[6]  K. Omote,et al.  Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain , 2008, Neuroscience.

[7]  Maree T. Smith,et al.  Oxycodone and morphine have distinctly different pharmacological profiles: Radioligand binding and behavioural studies in two rat models of neuropathic pain , 2007, PAIN.

[8]  R. Meyer,et al.  Lumbar sympathectomy attenuates cold allodynia but not mechanical allodynia and hyperalgesia in rats with spared nerve injury. , 2007, The journal of pain : official journal of the American Pain Society.

[9]  E. Kalso,et al.  Antinociception by Spinal and Systemic Oxycodone: Why Does the Route Make a Difference?: In Vitro and In Vivo Studies in Rats , 2006, Anesthesiology.

[10]  J. Traynor,et al.  Comparison of the Antinociceptive Response to Morphine and Morphine-Like Compounds in Male and Female Sprague-Dawley Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[11]  G. Bokoch,et al.  GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[12]  A. Adunsky,et al.  High Dose Controlled-Release Oxycodone in Hospice Care , 2006, Journal of pain & palliative care pharmacotherapy.

[13]  E. Kalso.  Proceedings of the Symposium “Updates of the Clinical Pharmacology of Opioids with Special Attention to Long-Acting Drugs”Oxycodone , 2005 .

[14]  C. Divgi,et al.  Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  A. Gordon,et al.  Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy , 2003, Pain.

[16]  J. Williams,et al.  Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone‐inducible mammalian expression system , 2003, British journal of pharmacology.

[17]  R. Portenoy,et al.  Controlled-release oxycodone for pain in diabetic neuropathy , 2003, Neurology.

[18]  P. Mantyh,et al.  Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain , 2002, Pain.

[19]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[20]  Joshua A. Bueller,et al.  Regional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain , 2001, Science.

[21]  M. Narita,et al.  Involvement of Spinal Protein Kinase Cγ in the Attenuation of Opioid μ-Receptor-Mediated G-Protein Activation after Chronic Intrathecal Administration of [d-Ala2,N-MePhe4,Gly-Ol5]Enkephalin , 2001, The Journal of Neuroscience.

[22]  H. Bertalanffy,et al.  The Significance of Intrathecal Opioid Therapy for the Treatment of Neuropathic Cancer Pain Conditions , 2001, Stereotactic and Functional Neurosurgery.

[23]  J. Dickenson,et al.  Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. , 2000, Molecular pharmacology.

[24]  P. Mantyh,et al.  Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord , 2000, Nature Medicine.

[25]  Paul Jacobsen,et al.  Breakthrough pain: characteristics and impact in patients with cancer pain , 1999, Pain.

[26]  I. Sora,et al.  Absence of G‐protein activation by μ‐opioid receptor agonists in the spinal cord of μ‐opioid receptor knockout mice , 1999, British journal of pharmacology.

[27]  S. Mercadante,et al.  Breakthrough pain in cancer patients: pathophysiology and treatment. , 1998, Cancer treatment reviews.

[28]  S. Grossman,et al.  Cancer pain management in developing countries: a mosaic of complex issues resulting in inadequate analgesia , 1998, Supportive Care in Cancer.

[29]  C Peter N Watson,et al.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. , 1998, Neurology.

[30]  A. Zangen,et al.  Nociceptive stimulus induces release of endogenous β-endorphin in the rat brain , 1998, Neuroscience.

[31]  Maree T. Smith,et al.  The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated , 1997, Pain.

[32]  E. Kalso,et al.  Controlled-release oxycodone and morphine in cancer related pain , 1997, Pain.

[33]  M. Levy.  Pharmacologic treatment of cancer pain. , 1996, The New England journal of medicine.

[34]  H. Loh,et al.  Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Lei Yu,et al.  Molecular cloning and functional expression of a mu opioid receptor from rat brain , 1994, Regulatory Peptides.

[36]  R. Melzack,et al.  Morphine injected into the habenula and dorsal posteromedial thalamus produces analgesia in the formalin test , 1985, Brain Research.

[37]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[38]  S. Snyder,et al.  Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.

[39]  R. Veatch,et al.  THE IMPORTANCE OF STERIC CONFIGUA. ION IN CERTAIN MORPHINNE-MIMETIC ACTIONS OF SYNTHETIC ANALGETICS. , 1964, The Journal of pharmacology and experimental therapeutics.

[40]  M. Weinstock,et al.  QUANTITATIVE STUDIES OF THE ANTAGONISM BY NALORPHINE OF SOME OF THE ACTIONS OF MORPHINE-LIKE ANALGESIC DRUGS. , 1964, British journal of pharmacology and chemotherapy.

[41]  R MELZACK,et al.  The perception of pain. , 1961, Scientific American.

[42]  Takako Miyoshi,et al.  Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models. , 2009, Journal of pharmacological sciences.

[43]  E. Aitini,et al.  Oxycodone Controlled-Release as First-Choice Therapy for Moderate-to-Severe Cancer Pain in Italian Patients , 2008, Clinical drug investigation.

[44]  N. Cherny.  New strategies in opioid therapy for cancer pain. , 2000, The Journal of oncology management : the official journal of the American College of Oncology Administrators.

[45]  P. Mantyh,et al.  Erratum: Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord (Nature Medicine (2000) 6 (521-528)) , 2000 .

[46]  S. Komiya,et al.  Bone tumors in the pelvis presenting growth during pregnancy , 1999, Archives of Orthopaedic and Trauma Surgery.

[47]  A. Zangen,et al.  Nociceptive stimulus induces release of endogenous beta-endorphin in the rat brain. , 1998, Neuroscience.

[48]  S. Lazareno.  Measurement of Agonist-Stimulated [ 35 S]GTPγS Binding to Cell Membranes , 1997 .

[49]  A I Basbaum,et al.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. , 1984, Annual review of neuroscience.

[50]  H. Loh,et al.  Genomic structure and analysis of promoter sequence of a mouse la opioid receptor gene , 2022 .